Skip to Content
Developmental Therapeutics Program (DTP)
Last Updated: 04/02/15

TPB Publications

1998 Abstracts/Presentations

  1. Mirsalis, J. C., D. G. Fairchild, S. J. Donohue, K. L. K. Duncan, J. E. Tomaszewski, C. A. Tyson, 1998. Gender-specific Toxicity of Ecteinascidin 743 in Surgically Altered Rats. [Abstract No. 254]. The Toxicologist, 42, 51-52.
  2. Chan, K.K., Chiu, M., Yu, C., Covey, J.M., Tomaszewski, J.E. 1998. Preclinical Pharmacokinetics of Halichondrin B (NSC-609395), a Natural Occurring Antitumor Macrolide from Sea Sponges, by Electrospray LC/MS. [Abstract No. 1544]. Proc. Amer. Assoc. Cancer Res., 39, 226.
  3. Egorin, M.J., Rosen, D.M., Wolff, J.H., Callery, P.S., Mussor, S.M., Eiseman, J.L. 1998. Metabolism of 17-(Allylamino)-17-demethoxygeldanamycin (17AAG) (NSC-330507) by Murine & Human Hepatic Preparations. [Abstract No. 3567]. Proc. Amer. Assoc. Cancer Res., 39, 524.
  4. Hill, D.L., Lin, T.H., Duncan, K.L.K., Smith A.C. 1998. Binding of UCN-01 to Plasma Proteins of Humans, Rats, and Dogs. [Abstract No. 2483]. Proc. Amer. Assoc. Cancer Res., 39, 364.
  5. Kuffel, M.J., Squillace, D.P., Ames, M.M. 1998. Cytochrome P450 and 17ß-Hydroxysteroid Dehydrogenase Oxidation of 2-Methoxyestradiol by Murine and Human Hepatic Microsomes. [Abstract No. 3566]. Proc. Amer. Assoc. Cancer Res., 39, 524.
  6. Squillace, D.P., Reid, J.M., Kuffel, M.J., Ames, M.M. 1998. Bioavailabilty and in Vivo Metabolism of 2-Methoxyestradiol in Mice. [Abstract No. 3560]. Proc. Amer. Assoc. Cancer Res., 39, 523.
  7. Brown, A.P., Rodvold, K.A., Tolhurst, T.A., Tomaszewski, J.E., Donohue, S.J. and Levine, B.S. 1998. Oral Bioavailability and Plasma Elimination Kinetics of (2-Chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) in the Rat and Dog. [Abstract No. 3572]. Proc. Amer. Assoc. Cancer Res., 39, 525.
  8. Hill, D.L., Noker, P.E., Coyne, J.M., Smith, A.C., Tomaszewski, J.E., Newman, R.A., & Page, J.G. 1998. Toxicity and Pharmacokinetics of EF-5 (NSC-684681) in Dogs Dosed by Intravenous Infusion. [Abstract No. 3546]. Proc. Amer. Assoc. Cancer Res., 39, 521.
  9. Page, J.G., Rogers, T.S., Fulton, R.B., Thompson, C.R., Hill, D.L., Smith, A.C., Tomaszewski, J.E. 1998. Toxicity of COL-3 to Rats and Monkeys. [Abstract No. 4054]. Proc. Amer. Assoc. Cancer Res., 39, 596
  10. Schindler-Horvat, J.E., Fairchild, D.G., Hassler, C., Tomaszewski, J.E., Donohue, S.J., Tyson, C.A. 1998. Toxicity of Jasplakinolide (NSC-613009) in Rats and Dogs. [Abstract No. 4063]. Proc. Amer. Assoc. Cancer Res., 39, 597.
  11. Parchment, R.E., Tomaszewski, J.E., Grieshaber, C.K., Valeriote, F.A., Corbett, T.A. and LoRusso, P.M. 1998. In Vitro Hematotoxicology Studies of Neutropenia Induced by the Novel Agent, XK469. [Abstract No. 205, p.54]. 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, The Netherlands.
  12. Tomaszewski, J.E., S.J. Donohue, A.P. Brown, B.S. Levine, R.L. Morrisssey, C.A. Carter, W.R. Waud and M.C. Alley. 1998. Preclinical Efficacy and Toxicity of (2-Chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU, NSC 364432). [Abstract No. 202, p.53]. 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, The Netherlands.

About the Branch Chief

For information regarding the TPB, please contact Dr. Jerry M. Collins, Associate Director, collinsje@mail.nih.gov